Combined central and peripheral demyelination

Clinical features, diagnostic findings, and treatment

A. Cortese, D. Franciotta, E. Alfonsi, N. Visigalli, E. Zardini, L. Diamanti, P. Prunetti, C. Osera, M. Gastaldi, G. Berzero, A. Pichiecchio, G. Piccolo, A. Lozza, G. Piscosquito, E. Salsano, M. Ceroni, A. Moglia, G. Bono, D. Pareyson, E. Marchioni

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Combined central and peripheral demyelination (CCPD) is rare, and current knowledge is based on case reports and small case series. The aim of our study was to describe the clinical features, diagnostic results, treatment and outcomes in a large cohort of patients with CCPD. Thirty-one patients entered this retrospective, observational, two-center study. In 20 patients (65%) CCPD presented, after an infection, as myeloradiculoneuropathy, encephalopathy, cranial neuropathy, length-dependent peripheral neuropathy, or pseudo-Guillain-Barré syndrome. Demyelinating features of peripheral nerve damage fulfilling European Federation of Neurological Societies/Peripheral Nerve Society (EFNS/PNS) electrodiagnostic criteria for CIDP were found in 23 patients (74%), and spatial dissemination of demyelinating lesions on brain MRI fulfilling the 2010 McDonald criteria for multiple sclerosis (MS) in 11 (46%). Two thirds of the patients had a relapsing or progressive disease course, usually related to the appearance of new spinal cord lesions or worsening of the peripheral neuropathy, and showed unsatisfactory responses to high-dose corticosteroids and intravenous immunoglobulins. The clinical presentation of CCPD was severe in 22 patients (71%), who were left significantly disabled. Our data suggest that CCPD has heterogeneous features and shows frequent post-infectious onset, primary peripheral nervous system or central nervous system involvement, a monophasic or chronic disease course, inadequate response to treatments, and a generally poor outcome. We therefore conclude that the current diagnostic criteria for MS and CIDP may not fully encompass the spectrum of possible manifestations of CCPD, whose pathogenesis remains largely unknown.

Original languageEnglish
Pages (from-to)182-187
Number of pages6
JournalJournal of the Neurological Sciences
Volume363
DOIs
Publication statusPublished - Apr 15 2016

Fingerprint

Demyelinating Diseases
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Peripheral Nervous System Diseases
Multiple Sclerosis
Therapeutics
Cranial Nerve Diseases
Intravenous Immunoglobulins
Peripheral Nervous System
Brain Diseases
Peripheral Nerves
Spinal Cord
Adrenal Cortex Hormones
Chronic Disease
Central Nervous System
Brain
Infection

Keywords

  • Acute disseminated encephalomyelitis
  • Chronic inflammatory demyelinating polyneuropathy
  • Combined central and peripheral demyelination
  • Guillain-Barré syndrome
  • Multiple sclerosis

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Combined central and peripheral demyelination : Clinical features, diagnostic findings, and treatment. / Cortese, A.; Franciotta, D.; Alfonsi, E.; Visigalli, N.; Zardini, E.; Diamanti, L.; Prunetti, P.; Osera, C.; Gastaldi, M.; Berzero, G.; Pichiecchio, A.; Piccolo, G.; Lozza, A.; Piscosquito, G.; Salsano, E.; Ceroni, M.; Moglia, A.; Bono, G.; Pareyson, D.; Marchioni, E.

In: Journal of the Neurological Sciences, Vol. 363, 15.04.2016, p. 182-187.

Research output: Contribution to journalArticle

@article{c6df620cd13d48b18b3c362bba76b5e6,
title = "Combined central and peripheral demyelination: Clinical features, diagnostic findings, and treatment",
abstract = "Combined central and peripheral demyelination (CCPD) is rare, and current knowledge is based on case reports and small case series. The aim of our study was to describe the clinical features, diagnostic results, treatment and outcomes in a large cohort of patients with CCPD. Thirty-one patients entered this retrospective, observational, two-center study. In 20 patients (65{\%}) CCPD presented, after an infection, as myeloradiculoneuropathy, encephalopathy, cranial neuropathy, length-dependent peripheral neuropathy, or pseudo-Guillain-Barr{\'e} syndrome. Demyelinating features of peripheral nerve damage fulfilling European Federation of Neurological Societies/Peripheral Nerve Society (EFNS/PNS) electrodiagnostic criteria for CIDP were found in 23 patients (74{\%}), and spatial dissemination of demyelinating lesions on brain MRI fulfilling the 2010 McDonald criteria for multiple sclerosis (MS) in 11 (46{\%}). Two thirds of the patients had a relapsing or progressive disease course, usually related to the appearance of new spinal cord lesions or worsening of the peripheral neuropathy, and showed unsatisfactory responses to high-dose corticosteroids and intravenous immunoglobulins. The clinical presentation of CCPD was severe in 22 patients (71{\%}), who were left significantly disabled. Our data suggest that CCPD has heterogeneous features and shows frequent post-infectious onset, primary peripheral nervous system or central nervous system involvement, a monophasic or chronic disease course, inadequate response to treatments, and a generally poor outcome. We therefore conclude that the current diagnostic criteria for MS and CIDP may not fully encompass the spectrum of possible manifestations of CCPD, whose pathogenesis remains largely unknown.",
keywords = "Acute disseminated encephalomyelitis, Chronic inflammatory demyelinating polyneuropathy, Combined central and peripheral demyelination, Guillain-Barr{\'e} syndrome, Multiple sclerosis",
author = "A. Cortese and D. Franciotta and E. Alfonsi and N. Visigalli and E. Zardini and L. Diamanti and P. Prunetti and C. Osera and M. Gastaldi and G. Berzero and A. Pichiecchio and G. Piccolo and A. Lozza and G. Piscosquito and E. Salsano and M. Ceroni and A. Moglia and G. Bono and D. Pareyson and E. Marchioni",
year = "2016",
month = "4",
day = "15",
doi = "10.1016/j.jns.2016.02.022",
language = "English",
volume = "363",
pages = "182--187",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",

}

TY - JOUR

T1 - Combined central and peripheral demyelination

T2 - Clinical features, diagnostic findings, and treatment

AU - Cortese, A.

AU - Franciotta, D.

AU - Alfonsi, E.

AU - Visigalli, N.

AU - Zardini, E.

AU - Diamanti, L.

AU - Prunetti, P.

AU - Osera, C.

AU - Gastaldi, M.

AU - Berzero, G.

AU - Pichiecchio, A.

AU - Piccolo, G.

AU - Lozza, A.

AU - Piscosquito, G.

AU - Salsano, E.

AU - Ceroni, M.

AU - Moglia, A.

AU - Bono, G.

AU - Pareyson, D.

AU - Marchioni, E.

PY - 2016/4/15

Y1 - 2016/4/15

N2 - Combined central and peripheral demyelination (CCPD) is rare, and current knowledge is based on case reports and small case series. The aim of our study was to describe the clinical features, diagnostic results, treatment and outcomes in a large cohort of patients with CCPD. Thirty-one patients entered this retrospective, observational, two-center study. In 20 patients (65%) CCPD presented, after an infection, as myeloradiculoneuropathy, encephalopathy, cranial neuropathy, length-dependent peripheral neuropathy, or pseudo-Guillain-Barré syndrome. Demyelinating features of peripheral nerve damage fulfilling European Federation of Neurological Societies/Peripheral Nerve Society (EFNS/PNS) electrodiagnostic criteria for CIDP were found in 23 patients (74%), and spatial dissemination of demyelinating lesions on brain MRI fulfilling the 2010 McDonald criteria for multiple sclerosis (MS) in 11 (46%). Two thirds of the patients had a relapsing or progressive disease course, usually related to the appearance of new spinal cord lesions or worsening of the peripheral neuropathy, and showed unsatisfactory responses to high-dose corticosteroids and intravenous immunoglobulins. The clinical presentation of CCPD was severe in 22 patients (71%), who were left significantly disabled. Our data suggest that CCPD has heterogeneous features and shows frequent post-infectious onset, primary peripheral nervous system or central nervous system involvement, a monophasic or chronic disease course, inadequate response to treatments, and a generally poor outcome. We therefore conclude that the current diagnostic criteria for MS and CIDP may not fully encompass the spectrum of possible manifestations of CCPD, whose pathogenesis remains largely unknown.

AB - Combined central and peripheral demyelination (CCPD) is rare, and current knowledge is based on case reports and small case series. The aim of our study was to describe the clinical features, diagnostic results, treatment and outcomes in a large cohort of patients with CCPD. Thirty-one patients entered this retrospective, observational, two-center study. In 20 patients (65%) CCPD presented, after an infection, as myeloradiculoneuropathy, encephalopathy, cranial neuropathy, length-dependent peripheral neuropathy, or pseudo-Guillain-Barré syndrome. Demyelinating features of peripheral nerve damage fulfilling European Federation of Neurological Societies/Peripheral Nerve Society (EFNS/PNS) electrodiagnostic criteria for CIDP were found in 23 patients (74%), and spatial dissemination of demyelinating lesions on brain MRI fulfilling the 2010 McDonald criteria for multiple sclerosis (MS) in 11 (46%). Two thirds of the patients had a relapsing or progressive disease course, usually related to the appearance of new spinal cord lesions or worsening of the peripheral neuropathy, and showed unsatisfactory responses to high-dose corticosteroids and intravenous immunoglobulins. The clinical presentation of CCPD was severe in 22 patients (71%), who were left significantly disabled. Our data suggest that CCPD has heterogeneous features and shows frequent post-infectious onset, primary peripheral nervous system or central nervous system involvement, a monophasic or chronic disease course, inadequate response to treatments, and a generally poor outcome. We therefore conclude that the current diagnostic criteria for MS and CIDP may not fully encompass the spectrum of possible manifestations of CCPD, whose pathogenesis remains largely unknown.

KW - Acute disseminated encephalomyelitis

KW - Chronic inflammatory demyelinating polyneuropathy

KW - Combined central and peripheral demyelination

KW - Guillain-Barré syndrome

KW - Multiple sclerosis

UR - http://www.scopus.com/inward/record.url?scp=84959311461&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959311461&partnerID=8YFLogxK

U2 - 10.1016/j.jns.2016.02.022

DO - 10.1016/j.jns.2016.02.022

M3 - Article

VL - 363

SP - 182

EP - 187

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

ER -